Positive Receptor Feedback during Lineage Commitment Can Generate Ultrasensitivity to Ligand and Confer Robustness to a Bistable Switch  by Palani, Santhosh & Sarkar, Casim A.
Positive Receptor Feedback during Lineage Commitment Can Generate
Ultrasensitivity to Ligand and Confer Robustness to a Bistable Switch
Santhosh Palani* and Casim A. Sarkar*y
*Department of Bioengineering and yDepartment of Chemical and Biomolecular Engineering, University of Pennsylvania, Philadelphia,
Pennsylvania 19104-6321
ABSTRACT Cytokines and lineage-speciﬁc transcription factors are critical molecular effectors for terminal differentiation
during hematopoiesis. Intrinsic transcription factor activity is often believed to drive commitment and differentiation, whereas
cytokine receptor signals have been implicated in the regulation of cell proliferation, survival, and differentiation. In
erythropoiesis, recent experimental ﬁndings provide direct evidence that erythropoietin (Epo) can generate commitment cues
via the erythropoietin receptor (EpoR); speciﬁcally, EpoR signaling leads to activation of the transcription factor GATA-1, which
then triggers transcription of erythrocyte-speciﬁc genes. In particular, activated GATA-1 induces two positive feedback loops in
the system through the enhanced expression of both inactive GATA-1 and EpoR, the latter of which is externally regulatable
by Epo. Based upon this network architecture, we present a mathematical model of GATA-1 activation by EpoR, which
bidirectionally links a lineage-speciﬁc receptor and transcription factor. Our deterministic model offers insight into stimulus-
response relationships between Epo and several downstream effectors. In addition to the survival signals that EpoR provides,
steady-state analysis of our model suggests that receptor upregulation during lineage commitment can also generate
ultrasensitivity to Epo and bistability in GATA-1 activity. These system-level properties can induce a switch-like characteristic
during differentiation and provide robustness to the mature state. The topology also suggests a novel mechanism for achieving
robust bistability in a purely deterministic manner without molecular cooperativity. The analytical solution of a generalized,
minimal model is provided and the signiﬁcance of each of the two positive feedback loops is elucidated through bifurcation
analysis. This network topology, or variations thereof, may link other receptor-transcription factor pairs and may therefore be of
general relevance in cellular decision-making.
INTRODUCTION
The process of cellular differentiation entails a complex se-
ries of events through which an uncommitted progenitor can
morph into a stable specialized cell. Although many of the
critical individual molecular components involved in speciﬁc
differentiation processes have been identiﬁed, the complex
interactions and topology of signaling and transcriptional
networks can lead to nonintuitive behavior. Mathematical
modeling and analysis can provide insights into the system-
level properties that arise from such an array of interactions.
In cellular processes in which a binary decision must be
made, bistability can be an important system-level property
that arises from the corresponding signaling networks.
Changes in the system input can toggle a bistable system be-
tween two steady states; additionally, the system can display
memory by sustaining a high (or low) steady-state response
after signiﬁcant reduction (or increase) in the magnitude of the
stimulus (1). Biological examples of bistability include cell-
cycle regulation in Xenopus oocytes (2) and Saccharomyces
cerevisiae (3), self-sustaining biochemical memory (4), syn-
thetic genetic switches (5–9), and differentiation of common
myeloid precursors into macrophages and neutrophils (10).
Bistability is often accompanied by ultrasensitivity to a stim-
ulus, another common property of nonlinear systems (11–13).
Since, there is growing evidence that cell differentiation is an
all-or-none ‘‘switch-like’’ event, rather than a continuous
transition of an unspecialized cell into a mature one (2,14),
mathematical modeling of the commitment process is attrac-
tive because the switch-like response and cellular memory
implicit in the biological process arise naturally in the for-
mulation of such nonlinear models.
Hematopoiesis, the formation of blood cells, takes place
in two distinct stages: primitive differentiation and terminal
differentiation. During primitive differentiation, a hemato-
poietic stem cell differentiates into a multipotent or bipotent
progenitor cell, which, upon terminal differentiation, gives
rise to a mature cell. It has been suggested that primitive
differentiation is primarily a stochastic process involving
differential expression of several intrinsic transcription fac-
tors, whereas terminal differentiation involves both cell-
intrinsic and cell-extrinsic factors (15,16). Lineage-speciﬁc
cytokines (extrinsic) and transcription factors (intrinsic) are
believed to be the important molecular components that af-
fect cell survival, proliferation, and commitment during ter-
minal differentiation.
Erythropoietin (Epo) is a hematopoietic cytokine respon-
sible for the proliferation, survival, and differentiation of
erythroid cells (17). The Epo receptor (EpoR) has a single
transmembrane domain, an extracellular domain for Epo
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binding, and an intracellular domain for signaling (18). In the
absence of ligand, Epo receptors exist predominantly as in-
active homodimers on the cell surface (19). Binding of Epo to
the receptor homodimer changes the orientation of the re-
ceptor subunits, which leads to activation of several signaling
cascades including the PI3K/AKT, STAT5-BclXL, and Ras/
MAPK pathways (20). Erythroid progenitors lacking func-
tional EpoR do not mature into erythrocytes and show phe-
notypic abnormalities (21,22).
The zinc-ﬁnger GATA-1 is a transcription factor that plays
a critical role in erythroid differentiation (23,24). It binds as
a monomer to the consensus sequence (A/T)GATA(A/G),
which is present in the promoter and enhancer regions of
virtually all erythroid-speciﬁc genes (25–28). GATA-1 un-
dergoes several posttranslational modiﬁcations (acetylation,
phosphorylation, sumoylation, and ubiquitination) that may
be critical for its optimal transcriptional activity (29). Anal-
ysis of the promoter regions of the EpoR gene shows no
TATA or CAAT box, but does reveal the presence of a
GATA-1 binding motif, thus providing a meaningful link
between a lineage-speciﬁc transcription factor and a lineage-
restricted receptor (30–32). Active GATA-1 also binds to the
regulatory region of its own gene, thereby enhancing its total
expression through a positive feedback loop (33–36). Dis-
ruption of the GATA-1 gene in murine embryonic stem cells
by homologous recombination blocks erythroid develop-
ment, emphasizing the absolute need for GATA-1 in red
blood cell maturation (37).
Common myeloid progenitors give rise to erythroid burst-
forming units (BFU-E), the earliest known erythroid pre-
cursor cells. BFU-E mature into erythroid colony-forming
units (CFU-E); this is accompanied by an increase in EpoR
expression and the cells become increasingly dependent on
Epo (38,39). EpoR and GATA-1 levels both rise in parallel
and reach their maximum during CFU-E maturation into
proerythroblasts and their subsequent differentiation into
early basophilic erythroblasts (40,41). Both GATA-1 and
EpoR levels fall during further maturation from the baso-
philic stage to the polychromatic stage as cells synthesize
large amounts of globins (38,41). Further differentiation from
polychromatic erythrocytes to reticulocytes is independent of
EpoR and GATA-1, as their levels fall sharply and the cells
also show a decrease in globin expression (38,41). Hence, it
is during the temporal window from an early CFU-E to a
basophilic erythroblast that EpoR and GATA-1 may act in
concert to drive commitment of the erythroid precursor to
terminal differentiation and induce the synthesis of globins.
Recent evidence suggests several modes of cross talk be-
tween EpoR signaling and GATA-1 transcriptional activity,
and analysis of these interactions may offer insights into the
commitment program during erythroid differentiation. In
brief, EpoR signaling via AKT can lead to GATA-1 activa-
tion; in return, active GATA-1 can upregulate synthesis of
both itself and EpoR (Fig. 1). Epo activates AKT by phos-
phorylating this kinase at Ser-473 in a PI3K-dependent
manner (42). The importance of AKT signaling in erythro-
poiesis was demonstrated in JAK2-deﬁcient fetal liver pro-
genitor cells: erythroid differentiation can be supported in
these cells by overexpressing active AKT and it can also be
inhibited by downmodulating AKT using RNA interference
(43). Active AKT appears to have a signiﬁcant role in en-
hancing GATA-1 transcriptional activity by mediating some
of its posttranslational modiﬁcations, including phosphoryl-
ation and acetylation. AKT phosphorylates GATA-1 at Ser-
310 and enhances its transcriptional activity in primary fetal
liver cells (42). However, mice with a S310A mutation in
GATA-1 showed no hematopoietic abnormalities during
normal or stress erythropoiesis, indicating that phosphoryl-
ation of GATA-1 is dispensable for red blood cell differen-
tiation and may only be required for maximal activity (44).
p300 and CREB binding protein (CBP) acetyltransferases
acetylate GATA-1 at lysine residues present in the C-terminal
tail of its zinc ﬁngers (45–47). In vivo chromatin immuno-
precipitation assays show that lysine to alanine mutations at
the acetylation residues dramatically impair GATA-1 associ-
ation with chromatin (48), suggesting that acetylation is crit-
ical for GATA-1-mediated gene expression. p300 and CBP
also have histone acetyltransferase (HAT) activity and may
play a role in enhanceosome stability by acetylating GATA-
1 and histones (49,50). AKT phosphorylates p300 at Ser-1834
and this has been shown to be essential for AT, HAT, and
transcriptional activity of p300 (51–53). Interestingly, Ser-
1834 lies in the E1A binding domain that is necessary for
binding of p300/CBP to GATA-1 (45). It has also been sug-
gested that phosphorylation may aid in GATA-1 binding to
CBP, since the Ser-310 residue of GATA-1 is within the
C-terminal acetylationmotif of GATA-1 (42). Taken together,
these results suggest an additional role for Epo (other than
providing survival and proliferation cues) in erythroid pre-
cursor commitment and differentiation by activating GATA-1
through the PI3K/AKT pathway and inﬂuencing the intrinsic
signals that lead to commitment and differentiation.
Based on this experimental evidence, we present a deter-
ministic model of the upregulation and activation of the
erythrocyte-speciﬁc transcription factor GATA-1, a ‘‘master
regulator’’ of erythrocyte commitment. Lineage speciﬁcation
models previously reported suggest that erythrocyte differ-
entiation from erythroid/myeloid bipotent precursor can arise
due to the differential expression of antagonistic transcription
factors (upregulation of GATA-1 and downregulation of
PU.1) driven primarily by cell-intrinsic events (54,55). These
models provide insight into the dynamics of a binary cell-fate
decision from the viewpoint of ‘‘multilineage priming’’,
auto-stimulation, and reciprocal repression.
The work presented here focuses on erythrocyte commit-
ment rather than differentiation, and examines how both
intracellular and extracellular factors may inﬂuence the cell-
fate decision. As depicted in Fig. 1, the topology of our
model captures the essential elements of outside-in signaling
(Epo-mediated activation of GATA-1), intracellular signal
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ampliﬁcation (GATA-1-mediated upregulation of GATA-1
synthesis), and inside-out signaling (GATA-1-mediated up-
regulation of EpoR). Using this model, we show that upre-
gulation of EpoR in erythroid precursor cells upon Epo
addition can generate ultrasensitivity to ligand as well as ro-
bust bistability in GATA-1 expression during commitment,
and this may provide ‘‘switch-like’’ differentiation charac-
teristics.
Further analysis of a generalized minimal model conﬁrms
that the topological connectivity of the two feedback loops
alone is both necessary and sufﬁcient for generating the
overall system dynamics. Although there are several ways of
achieving bistability (1,56), feedback loops are the most
commonly identiﬁed mechanism; however, feedback loops
that give rise to robust bistability in purely deterministic
models have, to date, been shown to be highly cooperative in
at least one reaction (57–60). Here, we present what we be-
lieve is a novel way of achieving robust bistability in cell
signaling networks without molecular cooperativity through
two linked positive feedback loops. This topology may have
general implications for cellular decision-making.
MODEL DEVELOPMENT
Model construction and description
The core reaction of the proposed erythrocyte commitment
model is the activation of GATA-1 by AKT through EpoR
signaling (Fig. 1, light gray background). Our model con-
centrates exclusively on the two positive feedback loops that
serve to increase the concentrations of the reactant species
(AKTpp and GATA-1) in this core reaction, which leads to
greater accumulation of GATA-1*, the activated form of a
‘‘master regulator’’ of erythrocyte-speciﬁc genes. The model
speciﬁcally incorporates the following components/motifs in
the feedback loops that may have an effect on the overall
system behavior:
1. EpoR homodimerization. Unlike many other cytokine-
receptor systems, EpoR homodimerizes (but does not
signal) before Epo addition, which should therefore
confer ultrasensitivity to the number of receptor dimers
available to bind Epo (19,20). This effect was modeled as
a two-step process of EpoR binding to JAK2 and EpoRJ
dimerizing to form EpoRJD. Alternatively, EpoR homo-
dimerization could be treated as a single-step process
without considering the effect of JAK2.
2. PI3K/AKT pathway. Signaling in the MAPK cascade has
been shown to convert graded signals into ultrasensitive
responses (61); therefore, the similar cascade structure in
the PI3K/AKT pathway might ultrasensitize the signals
from the cell surface to GATA-1.
3. Double phosphorylation of AKT. Recent reports have
shown that bistability in signaling circuits can arise from
multisite phosphorylation (56); hence, we explicitly
modeled AKT activation as two phosphorylation steps.
4. Transcription and translation. Delay in feedback loops
has been shown to generate interesting behaviors in
signaling networks (62), so these two processes were
modeled as separate steps. Additionally, explicit inclusion
of mRNA species in the model facilitates comparisons
with experimental microarray data (see the Supplementary
Material, Fig. S1, Data S1).
We have used a deterministic, ordinary differential
equation-based approach to model this signal transduction/
transcriptional network. Although this modeling frame-
work represents an ideal approximation of the true intra-
cellular milieu (63), it can still provide useful information
regarding the system dynamics, particularly for nonlinear
systems of the type studied here (64). In step 1 in Fig. 1,
JAK2 binds to the intracellular domain of EpoR to form a
receptor-JAK complex (EpoRJ). EpoRJ dimerizes to form
EpoRJD in step 3. EpoRJ and EpoRJD undergo constitutive
receptor endocytosis (steps 2 and 4). In step 5, Epo binds to
the extracellular domain of EpoRJD, forming the activated
complex (EpoRJD*) and the endocytosis of the complex is
shown in step 6. PI3K is activated (PI3K*) by the complex
and is deactivated by a phosphatase (steps 7 and 8). PI3K*
converts PIP2 to PIP3 in step 9. PIP3 binds to the PH domain
of AKT and phosphorylates AKT on Ser-473 and Thr-308
(steps 11–15). This doubly phosphorylated form of AKT
(AKTpp) catalyzes the activation of GATA-1 (step 16).
Activated GATA-1 (GATA-1*) is deactivated and degraded
in steps 17 and 26, respectively. Monomeric GATA-1* en-
hances transcriptional synthesis of nuclear EpoR mRNA
(EpoRmRNAn) and GATA-1 mRNA (GATA1mRNAn)
in steps 18 and 19. The nuclear mRNAs (EpoRmRNAn
and GATA1mRNAn) are translocated to the cytoplasm
(EpoRmRNAc and GATA1mRNAc, respectively), where
they are either translated to their corresponding protein forms
or degraded (steps 20–25).
EpoR and GATA-1 are present at basal levels in progenitor
cells before the addition of Epo. The basal expression of Epo
receptor may be independent of GATA-1 as there is also a
Sp1 binding site on the 1.7 kb 59-ﬂanking region of the EpoR
gene (31). Based on current evidence, it appears that, as EpoR
is transported to the cell membrane, it is rapidly bound by
JAK2 and homodimerizes (19,20). Accordingly, we have
assumed 90% of EpoR to be initially present in the dimeric
state, 9% to be monomers bound by JAK2, and 1% to be free
receptors. Activation and deactivation reactions of PI3K,
PIP2, GATA-1, and AKT are assumed to have Michaelis-
Menten kinetics. AKT phosphorylation is modeled as a
two-step process (65). Double phosphorylation of AKT by
39-phosphoinositide-dependent protein kinase 1 (PDK1) is
necessary for its complete activation (66,67). Dephospho-
rylation of PI3K*, PIP3, and AKTpp are implicitly modeled
without considering the rate of change of the phosphatases
involved. The role of AKTpp in GATA-1 activation is
modeled as a single enzymatic step, encompassing both
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direct (e.g., phosphorylation) and indirect (e.g., acetylation)
mechanisms. It is important to note that Epo may activate
GATA-1 by AKT-independent mechanisms, but this does
not change the qualitative nature of the model (see minimal
model below). The mRNA transcription rate is assumed to
saturate hyperbolically with active transcription factor con-
centration, a rapid-equilibrium approximation (68). The rate
of translation is approximated to be proportional to the con-
centration of the cytoplasmic mRNA (69). All degradation
reactions are modeled with ﬁrst-order kinetics.
Positive feedback loops
There are two feedback loops considered in this model. Since
GATA-1* positively autoregulates its own transcriptional rate,
reactions 19, 21, and 24 drive the ﬁrst positive feedback loop.
This loop increases the concentration of inactive GATA-1 in
the cell. The strength of this feedback is governed by the pa-
rameter F1V19, themaximal transcriptional rate of the GATA-1
gene, shown in reaction 19. GATA-1* is also shown to reg-
ulate the synthesis rate of EpoRJD through reactions 18, 20,
22, 1, and 3, which start the second positive feedback loop,
whose strength is denoted by F2V18, the maximal rate of pro-
duction of EpoR mRNA. In this loop, GATA-1* upregulates
the expression of EpoRJD, which in turn increases the number
of complexes formed on the cell surface and leads to the in-
crease in the concentration of activated AKT kinase (AKTpp).
In this model, F1 and F2 determine the relative strengths of the
feedback loops as V18 and V19 are kept equal and constant.
The core reaction in the model is the activation of GATA-
1 by AKTpp (reaction 16) and the two feedback loops work
synchronously to drive this reaction and produce GATA-1*,
which in turn drives both of the feedback loops and also reg-
ulates the transcription of other erythrocyte speciﬁc genes.
FIGURE 1 Kinetic model of the EpoR/GATA-1 network implicated in erythrocyte progenitor commitment. EpoR and GATA-1 are present at low basal
levels before the addition of Epo. Epo binds to EpoR homodimers (EpoRJD), thereby activating AKT through the PI3K/AKT pathway. Doubly phosphorylated
AKT (AKTpp) activates GATA-1 directly and indirectly through covalent modiﬁcations (modeled here as a single step). GATA-1*, the activated form of the
transcription factor, upregulates GATA-1 and EpoR gene expression by binding to GATA motifs present in the response elements of their corresponding
genes. The core reaction of the model is the activation of GATA-1 by AKTpp and is highlighted with a light gray background. The reactants in the open boxes
comprise one feedback process (with transcriptional strength F1), a synthesis loop that generates more inactive GATA-1 (substrate), and the species in the dark
gray boxes represent a second feedback process (with transcriptional strength F2), an Epo-regulated loop that makes more AKTpp (enzyme). Both feedback
loops provide inputs to the core reaction to form GATA-1* (product). All reactants except Epo and JAK2 are time variant. Reaction sets (1–6, 11, 20, 21, 23,
25, and 26), (7–10, 12–17, 22, and 24), and (18 and 19) are modeled with mass-action, Michaelis-Menten, and rapid-equilibrium kinetics, respectively. The
species names ending with mRNAc and mRNAn denote cytoplasmic and nuclear mRNA, respectively. Double-headed and single-headed solid arrows indicate
reversible and irreversible reactions respectively. Dashed arrows specify irreversible reactions (transcription, translation) in which reactants are not consumed.
*, p, and pp denote the activated, singly phosphorylated, and doubly phosphorylated forms of species. All reactions going to null denote ﬁrst-order degradation
processes. The values of the rate constants shown in the ﬁgure are given in the Supplementary Material, Table S5 (Data S1).
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Nondimensionalization and computation
The full model, which consists of 18 ordinary differential
equations derived from 27 reactions with 44 parameters, is
given in the Supplementary Material (Table S1, Data S1). To
simplify parameter estimation and mathematical analyses,
the model was completely nondimensionalized; the nondi-
mensional forms of the differential equations and the pa-
rameters are also given in the Supplementary Material
(Tables S2 and S3, respectively, Data S1). In the nondi-
mensional model, each reactant concentration is normalized
by the total concentration of its respective basal inactive
form. The species used in the mathematical analyses are Epo
receptor homodimer (EpoRJD), complex (EpoRJD*), acti-
vated AKT (AKTpp), and activated GATA-1 (GATA-1*).
The respective nondimensional forms of these reactants are
RJD½  ¼ EpoRJD½ 
EpoRT½ 0
; C½  ¼ EpoRJD*½ 
EpoRT½ 0
;
App½  ¼ AKTpp½ 
AKTT½  ; GA½  ¼
GATA-1*½ 
GATA-1T½ 0
:
A complete list of the nondimensional reactants and their
initial conditions is provided in Table S4 in the Supplemen-
tary Material (Data S1). The nondimensional equations were
solved using the Systems Biology Toolbox (SBtoolbox) for
MATLAB (The MathWorks, Natick, MA) (70). Parameter
sensitivity and parameter estimation were also performed
with SBtoolbox. MATLAB was used for analyzing bistabil-
ity and ultrasensitivity through steady-state response plots.
Parameter estimation and sensitivity analysis
Of the 44 parameters present in the model, 29 parameters
were incorporated directly from the literature, 8 parameters
were reﬁned from values provided in the literature, and the
remaining 7 parameters (V16, K16, V17, K17, F1, F2, k26) were
estimated to ﬁt time course measurements of GATA-1 DNA
binding activity during erythroid precursor commitment and
differentiation as reported by Dalyot et al. (41). Of these 7
parameters, the steady-state values of the reactants in the
model are highly sensitive only to F1, F2, and k26. To initially
compare the model to these experimental data, a negative
feedback loop was added to account for the degradation of
GATA-1* after progenitor commitment. This was necessary
since the experimental data cover a much broader temporal
window of the differentiation process, from GATA-1* pro-
duction in progenitors to complete GATA-1 degradation in
mature erythrocytes. We have assumed that the change in
GATA-1 DNA binding activity is due to corresponding
changes in the levels of GATA-1*. The ﬁtted parameters
were then used in mathematical analyses performed without
the negative feedback loop, as our model is only intended to
analyze the commitment decision of the progenitor cells
much earlier in the differentiation process and not account for
larger-scale phenotypic changes that are observed in mature
erythrocytes after commitment. Tables S5 and S6 (Data S1)
give the values of the estimated parameters and the initial
conditions of the reactants in the model. Parameter sensitivity
analysis was performed for the Epo receptor dimer, complex,
activated AKT, and activated GATA-1 by perturbing all 44
parameters and obtaining the normalized steady-state sensi-
tivities (ranging from 0 to 1). The most sensitive parameters
for each of the reactants are given in Fig. S2 (Data S1).
To further validate this fully parameterized EpoR/GATA-1
model (including the negative feedback loop), it was used to
perform kinetic simulations of total (nuclear 1 cytoplasmic)
EpoR and GATA1 mRNA levels. These simulations were
then compared to experimental measurements of EpoR
and GATA-1 mRNA levels (71), which were obtained from
the NCBI Gene Expression Omnibus (GEO) database (No.
GDS2431) and which represent experimental data entirely
independent from those used for parameter ﬁtting. The
comparison of model and experiment is given in Fig. S1
(Data S1) and suggests that the model is capable of making
accurate predictions.
Identiﬁcation of a generalized minimal model
To ascertain what topological features in the EpoR/GATA-1
model are responsible for its robust bistability, the model
was systematically reduced to a minimal form by stepwise
elimination of various linear topological motifs, including
EpoR homodimerization, PI3K/AKT cascading, multisite
phosphorylation, and individual transcription and translation
steps (data not shown). Conversely, both feedback loops
were critical for robust bistability (see Results).
The minimal model (see Fig. 6) consists of the following
reactions. The cell-surface receptor and the inactive lineage-
speciﬁc transcription factor (InactiveTF) are expressed at
basal (ligand-independent) levels in the naı¨ve cell. After
addition of ligand, a fraction of the cell-surface receptors
become complexes (step 2) and transmit a downstream signal
to enzymatically activate the transcription factor (step 4).
Constitutive receptor endocytosis, complex internalization,
and InactiveTF degradation reactions are shown in steps 1, 3,
and 8, respectively. The active transcription factor (Ac-
tiveTF) can then upregulate the expression of both receptor
and inactive transcription factor (steps 6 and 7, respectively).
ActiveTF can be deactivated or degraded (steps 5 and 9, re-
spectively). The activation of transcription factor by complex
and its deactivation are modeled as single enzymatic steps
and are assumed to have Michaelis-Menten kinetics. Com-
plex internalization and all degradation reactions are modeled
to have ﬁrst-order kinetics. The transcription and translation
reactions are modeled as a single step, where the rate of
protein formation is assumed to saturate hyperbolically with
the concentration of active transcription factor. The state of
the system is represented by the concentration of ActiveTF;
high levels denote the on-state (committed state) and low
levels denote the off-state (naı¨ve state).
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Nondimensionalization and computation of the
minimal model
The dimensional and nondimensional forms of the minimal
model, each consisting of four differential equations, are
provided in the Supplementary Material (Tables S7 and S8,
Data S1). The species present in the minimal model are lig-
and (L, time invariant), receptor (R), complex (C), inactive
transcription factor (ITF), and active transcription factor
(ATF). The nondimensionalization was performed in a
manner analogous to the EpoR/GATA-1 model (Tables S9
and S10, Data S1):
L½  ¼ Ligand½ 
Kd
; R½  ¼ Receptor½ 
Receptor½ 0
; C½  ¼ Complex½ 
Receptor½ 0
;
ITF½  ¼ InactiveTF½ 
InactiveTF½ 0
; ATF½  ¼ ActiveTF½ 
InaciveTF½ 0
:
The system of differential equations was solved analytically
using Maple (Maplesoft, Waterloo, Canada) and the full
solution for all reactants is given in the Supplementary
Material (Table S11, Data S1). Bistability and bifurcation
analyses were performed using MATLAB. Parameter sensi-
tivity analysis was performed using SBtoolbox. The most
sensitive parameters for each reactant are provided in Fig. S3
and the values of the kinetic parameters in this model are
given in Table S12 (Data S1).
RESULTS
Bistability and ultrasensitivity in the
EpoR/GATA-1 network
Stimulus/response plots have been used to predict bistability,
hysteresis, and ultrasensitivity in molecular networks (2,5).
The system is induced over a wide range of input stimuli and
the corresponding responses are obtained after the system
reaches steady state. The state of our EpoR/GATA-1 network
is represented by the concentration of GATA-1*; high levels
(obtained from both accumulation and activation of GATA-1)
denote the on-state (committed state) and low levels denote
the off-state (uncommitted state). In these simulations, Epo
was considered to be the stimulus, and the responses of im-
portant downstream effectors activated by the ensuing sig-
nals were analyzed. In Fig. 2, the steady-state values of the
nondimensionalized reactants (RJD, C, App, GA) are plotted
against the concentration of Epo normalized to its dissoci-
ation constant (Kd ¼ 58 pM (72)). When [Epo] ¼ 0, the
system is in the off-state, with RJD at its basal steady-state
value of 0.45, and C, App, and GA all at zero, as there are no
complexes. As the Epo concentration increases from 0, the
steady-state value of the Epo receptor dimer decreases (Fig.
2 A) as a result of complex formation (Fig. 2 B) and there is
a subsequent marginal increase in App and GA (Fig. 2, C and
D). As the concentration of Epo is further increased to 0.96
Kd, the number of complexes formed increases, but this is still
not sufﬁcient to maintain the positive feedback loops and the
system remains in the off-state. Only when the input stimulus
exceeds 0.96 Kd does the system switch to the on-state, as the
complexes can then generate enough AKTpp for GATA-1*
levels to exceed the threshold concentration needed to sus-
tain the feedback loops. Therefore, the system exhibits ul-
trasensitivity for a small perturbation in the concentration of
Epo about 0.96Kd. The on-state is accompanied by a large burst
of GATA-1*, an event known to precede the accumulation of
various erythroid speciﬁc genes (41). The system continues to
remain in the on-state with further increase in Epo levels.
To explore whether this network can exhibit memory, the
system was taken to the on-state by increasing the concen-
tration of Epo to its Kd value. The stimulus was then reduced
to 0.96Kd and the system was allowed to reach steady state. It
can be seen from the plots that the system remains in the on-
state as the active positive feedback loops can sustain the
system in the committed state. Thus, the downstream effec-
tors in the system exhibit hysteresis with respect to cytokine
stimulus. As the Epo concentration is further reduced from
0.96 Kd to 0.008 Kd, the steady-state value of RJD increases
since less complexes are formed and, in turn, there is a re-
duction in the levels of App; nonetheless, the number of
complexes is still sufﬁcient to sustain the feedback loops and
to maintain high levels of GATA-1*. As Epo levels are re-
duced below 0.008 Kd, the system switches back to the off-
state due to a lack of sufﬁcient Epo-mediated signaling.
When the system is in the committed state, removal of the
stimulus below the threshold level does not immediately
bring the system back to the off-state, instead exhibiting
bistability over a large range of stimulus concentration. This
bistable expression of GATA-1* can reduce the sensitivity of
the system to noise by necessitating a high Epo concentration
to initially achieve the on-state and, thereafter, by providing
marked robustness to the active state. Though the on-state is
still maintained when the stimulus level is reduced ;120-
fold below the threshold concentration, further decreases in
Epo concentration drive the system back to the off-state,
suggesting that it is not completely irreversible. This is in
accord with the phenotypic change observed after commit-
ment during which the cell becomes increasingly indepen-
dent of EpoR signaling and GATA-1 levels start to fall. The
high expression of GATA-1 achieved by Epo induction at
commitment can initiate chromatin rearrangements and ex-
pression of lineage speciﬁc genes, thereby ‘‘locking’’ the cell
in the mature state. The steady states plotted in Fig. 2 are only
the stable values; the unstable steady states are omitted, as
they are not experimentally accessible.
Pretreatment can change the threshold
concentration of the stimulus
The steady-state response plot of GA (Fig. 2 D) shows that
the Epo concentration has to be.0.96Kd for the system to be
in the on-state. Is there a way to attain the on-state for values
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of Epo less than the threshold concentration? Given the
memory implicit in this network, we hypothesized that
transient pretreatment of cells with high concentrations of
Epo should inﬂuence their commitment decision since the
switch to the on-state is determined by the number of com-
plexes needed to sustain the positive feedback loops. If the
cell were pretreated with a high concentration of Epo for a
ﬁxed amount of time, it should still be possible to achieve the
on-state even if the Epo concentration was then reduced to a
level lower than the threshold concentration (0.96 Kd), since
there would be an appropriate accumulation of multiple ac-
tivated species during pretreatment. To test this using our
model, the concentration of Epo during pretreatment was
ﬁxed at its Kd value and was then reduced to the value given
on the x axis in Fig. 3. The minimum pretreatment time re-
quired for the system to attain the on-state for a range of
constant Epo concentrations lower than the threshold con-
centration is plotted in Fig. 3. The corresponding plots of
RJD, C, App, and GA requirements to achieve the on-state
for lower Epo concentrations are similar and are given in the
Supplementary Material (Fig. S4, Data S1). For Epo con-
centrations .0.96 Kd, the threshold concentration, the cell
does not require pretreatment for commitment. As the Epo
concentration is reduced from 0.96 Kd to 0.008 Kd (a range
that corresponds precisely to the bistable window in Fig. 2),
the pretreatment time required to accumulate sufﬁcient
GATA-1* to attain the on-state increases exponentially.
Reducing the Epo concentration below 0.008 Kd, does not
bring the system to the on-state for any pretreatment time, as
the system is in the monostable off-state below this Epo
concentration (see Fig. 2).
Double positive feedback loops lead to
robust bistability
The EpoR/GATA-1 network consists of two positive feed-
back loops that coordinate to create a burst of GATA-1*, an
event critical for erythrocyte commitment. The ﬁrst feedback
loop is the transcription of GATA1 by GATA-1*, which in-
creases the concentration of inactive GATA-1 (substrate),
FIGURE 2 Nondimensionalized steady-state response plots: (A) Epo receptor dimer [RJD]. (B) Epo-Epo receptor complex [C]. (C) Activated AKT [App].
(D) Activated GATA-1 [GA]. The stimulus, Epo, is normalized to its Kd value and each downstream effector is normalized to the total concentration of its
respective basal inactive form. The plots show that, for the ﬁtted values of F1 (0.04) and F2 (0.123), the system is ultrasensitive to Epo and exhibits bistability
for a wide range of Epo concentrations (0.008–0.96 Kd).
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and the second feedback loop is the transcription of EPOR by
GATA-1*, which leads to an increase in the levels of AKTpp
(enzyme) in the presence of Epo. Parameters F1 and F2
govern the maximum transcriptional rates of GATA1 and
EPOR, respectively, and hence represent the strength of the
GATA-1*/GATA-1 and GATA-1*/EpoR/AKTpp feedback
loops, respectively. The parameter-ﬁtted values of F1 and F2
are 0.04 and 0.123, which correspond to a steady-state value
of GA ¼ 295 as seen in Fig. 2 D. In addition to other epi-
genetic factors, one possible explanation for the difference in
the transcriptional rates of GATA1 and EPOR could be the
distinct mechanisms by which GATA-1 binds to its con-
sensus sequence present in the promoter regions of these
genes (32,34)). It should be noted that the two positive
feedback loops are interdependent (linked via the GATA-
1 activation reaction; reaction with light gray background
in Fig. 1) and are necessary for the commitment decision to
accumulate GATA-1*. When F1 ¼ 0, the cell cannot make
more inactive GATA-1, and can only activate the existing
low levels of GATA-1, so the system stays in the off-state for
any value of F2 . 0; similarly, when F2 ¼ 0, the cell cannot
make enough surface complexes to activate GATA-1 via
AKTpp, so the system remains in the off-state for any
physiologically reasonable value of F1 . 0. For very large
values of F1, however, high levels of GATA-1* can be
achieved, albeit in a manner that does not impart memory to
the system (the stimulus/response plot in this case is hyper-
bolic and monostable everywhere).
Fig. 4 A shows a three-dimensional (3D) plot of the steady-
state value of GA as a function of F1 and F2 when the Epo
concentration is equal to its Kd. Changing the values of F1
and F2 can switch the system from the off-state to the on-state
as well as change the set point of the reactants—speciﬁcally
GA—in the on-state. As seen from the plot; if either F1 or F2¼
0, the system is always in the off-state, regardless of the strength
of the other feedback process. For the estimated value of F1 ¼
0.04, as we increase F2 from 0, the system remains in the off-
state until F2 reaches 0.118. Any increase of F2 over 0.118
causes the system to switch to the on-state with a GA set point
value of 295. Further increasing F2 does not change the value of
GA and the system remains in the on-state. For the estimated
value of F2 ¼ 0.123, as we increase F1 from 0, the system
remains in the off-state until F1 ¼ 0.01, at which point the
FIGURE 3 Minimum pretreatment time required for the system to attain
the on-state for a range of Epo values lower than the threshold concentration
(0.96 Kd). Epo is normalized to its Kd. The pretreatment concentration of
Epo is kept at its Kd value and is thereafter reduced to the value given on the
x axis. The plot suggests that for Epo concentrations .0.96 Kd, the cell
should not require pretreatment and, for values less than the threshold
concentration, the pretreatment time increases dramatically with decreases in
Epo concentration. For Epo values ,0.008 Kd, the system will always
remain in the monostable off-state for any pretreatment time (cf. Fig. 2).
FIGURE 4 Effect of the two positive feedback loops on the on-state GA
value. (A) Steady-state GA values as a function of F1 and F2; Epo is kept at
its Kd value. For the estimated values of F1 (0.04) and F2 (0.123), the system
is strongly F1-limited. (B) Corresponding phase diagram of the 3D plot
showing the off-state region, the F1-limited on-state, and the F2-limited on-
state. Increasing the values of F1 and F2 increases the on-state set point of
GA in the F1-limited and F2-limited regions, respectively. The EpoR/
GATA-1 system is likely to behave as an F1-limited system due the high
GA values required to be F2 limiting.
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system switches to the on-state with a low GA set point value.
As we further increase F1 to 0.04, the system stays in the on-
state and increases the GA steady-state value to the estimated
value of 295. When F1 is increased beyond 0.04, the steady-
state value of GA increases and saturates at an F1 value of 1.2.
A top view of the 3D plot is given in Fig. 4 B to address the
effect of changes in F1 and F2 on the set point of GA in the on-
state. In this phase diagram, the on-state is divided into two
regions: F1-limiting, where an increase in F1 (but not F2) will
increase the set point of GA in the on-state, and F2-limiting,
where an increase in F2 (but not F1) will increase the set point
of GA in the on-state. It can also be seen that the critical value
of F2 above which the system attains the on-state slightly
decreases as we increase F1 and the critical line eventually
asymptotes at F2¼ 0.05 for very high F1. The EpoR/GATA-1
system is likely to always be F1-limited because of the ex-
tremely high GATA-1 levels required to be F2-limited.
Steady-state response plots of GA for several values of F1 and
F2, spanning both F1- and F2-limited regions, are given in
Fig. S5 (Data S1).
Bistable expression of GATA-1*
The steady-state response plot in Fig. 2 D shows the wide
range of Epo concentrations in which GATA-1* exhibits
bistable expression for the ﬁtted F1 and F2 values. To un-
derstand the inﬂuence of the two positive feedback loops in
deﬁning the bistable window, we plotted the monostable
(either ON or OFF) and bistable (ON and OFF) GATA-1*
regions as a function of Epo concentration and feedback
strength (Fig. 5). Here, the F1 and F2 values are chosen to
cover both the F1- and F2-limiting regions as shown in Fig. 4
B. In Fig. 5 A, a log-log plot of F1 versus [Epo]/Kd, with F2
constant (0.20), shows the regions of monostable and bistable
expression of GATA-1*. At low F1 values, the system only
achieves bistability for a narrow range of Epo concentrations.
As we increase F1, the bistable window increases and remains
constant for larger F1 values. The increase in the bistable
window is only due to the decrease in the bistable-on to
monostable-off transition concentration, as the bistable-off to
monostable-on threshold concentration remains constant for
all values of F1. This reveals that the Epo concentration at
which the system initially switches to the on-state is inde-
pendent of F1. However, F1 governs the extent of memory in
the system by changing the Epo concentration at which the
system switches from the on-state to the off-state. Fig. 5 B
shows a semilog plot of F2 versus [Epo]/Kd, with F1 constant
(1.8). For values of F2 ,0.08, the system remains in the
off-state for all Epo concentrations. The system attains the
FIGURE 5 Bistable expression of GATA-1*. (A) A log-log plot showing
the change in the bistable expression of GATA-1* for varying F1 (F2 ¼
0.20). The threshold Epo concentration needed to achieve the on-state
appears to be independent of F1. The maximum bistable window achievable
is dependent on F2; however, the width of the bistable window is F1-
dependent for lower F1 values. (B) A semi-log plot showing the bistable
expression of GATA-1* for changing F2 values (F1 ¼ 1.8). There appears to
be a threshold F2 value below which the system is purely monostable.
Increasing F2 increases the width of the bistable window and, to a lesser
extent, decreases the threshold Epo concentration required to reach the on-
state. (C) Narrow bistable expression of GATA-1* for various F2 values
when F1 ¼ 0. The ON* state denotes an on-state due to activation but no
accumulation. This state would not commit a cell to differentiate due to low
basal levels of GATA-1. When F2 ¼ 0, the system is monostable for any F1
value (e.g., the x axis in Fig. 5 B).
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on-state for higher F2 values and also exhibits bistability for a
wide range of Epo concentrations. In contrast to Fig. 5 A, the
bistable window in Fig. 5 B shifts as we increase F2 due to a
substantial decrease in the bistable-on to monostable-off
transition concentration as well as a smaller decrease in the
bistable-off to monostable-on threshold concentration. This
indicates that F2 plays a role in determining the Epo con-
centration at which the system reaches on-state as well as in
governing the magnitude of memory in the system.
Since basal levels of inactive GATA-1 are low, the system
needs both F1 (for accumulation of GATA-1) and F2 (for
activation of GATA-1) to attain the on-state (accumulation of
activated GATA-1). For systems having a high basal
expression level of inactive transcription factor or lineage-
speciﬁc receptor (though neither is the case for the erythro-
cyte differentiation problem), it becomes relevant to examine
how bistability may be achieved. Can such systems poten-
tially attain the on-state* (activation, no accumulation) even
if F1 ¼ 0 or F2 ¼ 0? We tested this using our EpoR/GATA-1
model, with F1 ﬁxed at 0. Fig. 5 C shows the bistable ex-
pression of the active transcription factor in the absence of F1.
For a given F2, the Epo concentration at which the system
attains the on-state does not change when compared with Fig.
5 B, but the respective concentration at which the system
switches back to the monostable off-state is increased dra-
matically, thus narrowing the bistable window, or memory,
in the system. A system that has feedback 1 (upregulation of
GATA-1 by GATA-1*) but no feedback 2 (upregulation of
EpoR by GATA-1*) does not exhibit bistability for any value
of F1, conﬁrming the observation that autoregulating positive
feedback loops without cooperativity do not show bistability
in deterministic models (57,58); bistability in a system
lacking feedback 2 can be recovered by incorporating the
need for transcription factor dimerization for activation (data
not shown). In summary, this shows that the bistability and
ultrasensitivity achieved in the EpoR/GATA-1 model were
primarily due to the presence of feedback 2, and that feed-
back 1 only plays a role in increasing the extent of memory in
the system. The values of F1 and F2 may also change during
the differentiation process, thus dynamically modulating the
robustness of the system, though this time dependence was
not considered here.
Construction of a generalized minimal model
The EpoR/GATA-1 model exhibits ultrasensitivity and
bistability for a wide range of Epo, F1, and F2 values. The
structural aspects of the EpoR/GATA-1 model are the two
linked positive feedback loops, receptor homodimerization,
PI3K/AKT signaling pathway, double phosphorylation of
AKT, and the transcription and translation steps. We sys-
tematically developed and tested various submodels of the
parent model to identify the dispensable steps and to obtain a
generalized minimal model that still retains the ultra-
sensitivity and robust bistability of the parent model (data not
shown). This analysis revealed that the two positive feedback
loops were both necessary and sufﬁcient for recapitulating
the overall system behavior of the full EpoR/GATA-1 model.
This reduced lineage-speciﬁc receptor/transcription factor
model (Fig. 6) includes only four time-dependent species:
receptor (R), complex (C), and inactive (ITF) and active
(ATF) transcription factor. This model was solved analyti-
cally and the exact solution for each of the four reactants was
determined (Table S11, Data S1). The steady-state response
plots for these reactants for selected values of F1 and F2 are
given in Fig. S6 (Data S1). The bistability plots of ATF (Fig.
S7, Data S1) in the minimal model closely mimic those in the
EpoR/GATA-1 model (Fig. 5).
FIGURE 6 Generalized minimal model for lineage com-
mitment. Receptor and Inactive Transcription Factor (In-
activeTF) are present at basal levels before the addition of
ligand. Ligand binds to Receptor to form Complex and
activates InactiveTF to form Active Transcription Factor
(ActiveTF). ActiveTF upregulates the levels of InactiveTF
and Receptor through two positive feedback loops. Reaction
sets (1–3, 8, and 9), (4 and 5), and (6 and 7) are modeled with
mass-action, Michaelis-Menten, and rapid-equilibrium ki-
netics, respectively. Double-headed and single- headed solid
arrows indicate reversible and irreversible reactions, respec-
tively. Dashed arrows specify irreversible transcriptional
activation and translation reactions (modeled as a single
step). All reactants except ligand are time variant. All
reactions going to null denote ﬁrst-order degradation pro-
cesses. The values of the rate constants shown in the ﬁgure
are given in Table S12 (Data S1). (Inset) A further simpliﬁed
schematic of the minimal model highlighting the two feed-
back loops. L, R, ITF, and ATF denote the nondimensional
forms of Ligand, Receptor, InactiveTF, and ActiveTF,
respectively. Basally expressed R converts basally expressed ITF to ATF only in the presence of L. ATF upregulates itself by inducing the expression of
both ITF (with transcriptional strength F1) and R (with transcriptional strength F2). It should be noted that positive feedback to ITF is intrinsically regulated,
whereas positive feedback via R (to activate ITF) is dependent on the external stimulus L.
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Bifurcation analysis of the minimal model
Unlike the EpoR/GATA-1 model, the minimal model can be
solved analytically, which can prove useful in understanding
the contributions of each of the two positive feedback loops
to the overall behavior of the system. The solution curves of
ATF are plotted against L (normalized to its Kd) for various
values of F2 holding F1 constant at 20 as shown in Fig. 7 A.
The solid lines and the dotted lines denote the stable and
unstable roots, respectively. For low values of F2 (0.01), the
system has only two real roots (one stable and one unstable)
and is purely monostable for all ligand concentrations. As
F2 is increased to 0.1, the expression of the ActiveTF be-
comes narrowly bistable, with the endpoints of this bistable
FIGURE 7 Bifurcation analysis for the
minimal model. (A) Solution curves ob-
tained from the analytical solution of
nondimensionalized Active Transcription
Factor (ATF) are plotted against ligand
concentration normalized to its Kd (L)
by varying F2 (0.01, 0.1, 1, and 10); F1 is
held constant at 20. The solid lines and
the dotted lines denote the stable and
unstable roots, respectively. For low F2
values, the system is purely monostable.
As we increase F2, two saddle-node bi-
furcations emerge and they determine
the width of the bistable window and the
threshold ligand concentration neces-
sary to reach the on-state. As we further
increase F2, the solution curves intersect
to form a transcritical bifurcation. The
saddle-node set points and the transcrit-
ical set point (maximum achievable on-
state value) are F2- and F1-dependent,
respectively. (B) F1 is varied (0, 4.3, 20,
and 200); F2 is held constant at 10. The
system can achieve bistable expression
of ATF even when F1 ¼ 0. As we in-
crease F1, the bistable window increases
and reaches a maximum width, which is
determined only by the F2 value. In-
creasing F1 further increases the on-state
set point value of ATF but has no effect
on the threshold ligand concentration
required to reach the on-state.
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window deﬁned by two saddle-node bifurcations that appear
to depend on F2 but not on F1 (see below). The degree of
bistability increases dramatically as F2 is increased to 1 and
then to 10. It can be seen that, for these larger F2 values, the
solution curves intersect to form a transcritical bifurcation.
The transcritical set point, which constrains the maximum
theoretical value of ATF, seems to be independent of F2. The
transcritical bifurcation also divides the bistable window into
F1-limiting (right of the transcritical bifurcation point; con-
stant on-state value) and F2-limiting regions (left of the tran-
scritical bifurcation point; variable on-state value). For low F2
values, the bistable region is completely F2-limited and as we
increase F2, the bistable region becomes increasingly F1-lim-
ited. Finally, it can also be observed that the threshold ligand
concentration to achieve the on-state decreases as we increase
the F2 value.
Fig. 7 B shows the bifurcation diagrams for ATF plotted
against L by varying F1 and keeping F2 constant at 10. Unlike
the previous case (Fig. 7 A), the system can achieve bist-
ability over a narrow range of L by forming two saddle-node
bifurcations even when F1 is zero. As we increase F1, the size
of the bistable window and the on-state set point value both
increase. At a critical value of F1 (here 4.3), the maximum
bistable window is achieved, coincident with the appearance
of an apparent subcritical pitchfork bifurcation at the lowest
value of L at which the system is still bistable. At this F1 value,
the set point of the ATF in the bistable region is completely
F1-limited. As F1 is increased beyond 4.3, the solution curves
form a transcritical bifurcation similar to that seen in Fig. 7 A.
As we further raise the value of F1 to 20 and then 200, the
value of L at which the transcritical bifurcation occurs shifts
from low to high, making the bistable region increasingly F2-
limited. This is in contrast to Fig. 7 A, where the transcritical
bifurcation point moves from right to left and the bistable
region becomes increasingly F1-limited as we increase F2.
Importantly, increasing F1 augments the maximum on-state
set point value of ATF but has no effect on the threshold
ligand concentration necessary for achieving the on-state.
By comparing the bifurcation plots of ATF in Fig. 7 with
various plots of activated GATA-1 (Fig. 2 D, Fig. 5, and Fig.
S5 in Data S1), the following conclusions can be deduced for
the EpoR/GATA-1 system: the width of the bistable region
and the range of GATA-1* values in the on-state can both
depend on F1 (under F1-limited conditions) and/or F2 (under
F2-limited conditions); the maximum GATA-1* value in the
on-state is determined by F1; the threshold Epo concentration
at which the system switches to the on-state is dictated by F2;
the maximum bistable window achievable is set by F2; and,
the system requires an F2 value above a critical threshold to
exhibit bistability.
DISCUSSION
EpoR and GATA-1 are both essential for erythrocyte pre-
cursor commitment and differentiation, and we present here a
deterministic model that bidirectionally links the lineage-
speciﬁc receptor and transcription factor. Based on recent
biochemical data (42,43,45,53), we chose the PI3K/AKT
cascade as the signaling pathway that connects EpoR and
GATA-1. The model accounts for basal expression of EpoR
and GATA-1, Epo binding to EpoR to activate the PI3K/AKT
pathway, activation of GATA-1 by phosphorylated AKT,
positive autoregulation of GATA-1 expression by GATA-1*,
and upregulation of EpoR expression by GATA-1*.
To gain mechanistic insights into system behavior, we
chose to focus on this small set of critical molecular effectors
implicated in erythropoiesis. However, it should be noted that
our explicitly modeled topology represents only a fraction of
the full regulatory network and, therefore, inferring cell fate
from the level of a single metric (e.g., GATA-1*) represents
an approximation of a high-dimensional attractor (55,73).
Signaling pathways that were excluded from our model in-
clude JAK2/STAT5/BclXL, which provides antiapoptotic
signals during erythrocyte differentiation (74), and Ras/
MAPK, which is involved in cell survival (75), cell-cycle
regulation (76), and the degradation of DNA-bound GATA-1
(77). Also, the JAK2/STAT5 pathway activated by Epo can
initiate a negative feedback loop on the PI3K/AKT pathway
by activating SOCS proteins that can suppress Epo receptor
signaling (78,79). Our model, despite neglecting these ad-
ditional complexities, can nevertheless effectively capture
the system dynamics observed in multiple indepedent ex-
perimental data sets (see Fig. S1, Data S1).
Through steady-state response plots (Fig. 2) and bistability
plots (Fig. 5), it was revealed that the EpoR/GATA-1 net-
work can exhibit ultrasensitivity and bistability. Since these
properties may play important roles in erythrocyte commit-
ment, it was informative to probe the role of positive feed-
back in such a topology. As shown in Fig. 7 A, positive
receptor feedback can ultrasensitize the system to ligand and
can generate a considerable memory effect once the on-state
is achieved. Other transcription factors (e.g., GATA-3 (80))
are believed to be intracellularly ampliﬁed through a classical
autoregulatory positive feedback loop: synthesis of the new
transcription factor is followed by dimerization (or higher
order oligomerization) and the complex is then transcrip-
tionally active. If this is sufﬁcient for programming cell fate,
why, then, might a transcription factor such as GATA-1 have
evolved to upregulate a lineage-speciﬁc receptor as well?
The answer may lie in the different modes of activation.
Whereas the dimerization step closes the positive feedback
loop for some transcription factors, experimental evidence
suggests that GATA-1 binds DNA as a monomer (34,81,82)
and shows no detectable DNA-binding ability before the
addition of Epo (41). Thus, EpoR signaling may be necessary
to close the GATA-1 autoregulatory loop by activating the
transcription factor via AKT. By upregulating EpoR to in-
crease its own activation, GATA-1 can effectively mimic the
molecular cooperativity of other transcription factors in
generating robust network bistability without employing any
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cooperative reactions. (The importance of cooperativity in
achieving bistability is restricted to the class of deterministic
models discussed in this work; it is indeed possible to achieve
steep sigmoidal responses through nonidealities such as
molecular crowding (83), stochastic focusing (84), and di-
mensionally restricted reactions (63).)
Two unique elements of the EpoR/GATA-1 model should
be highlighted. First, by decoupling the synthesis and acti-
vation steps in the positive GATA-1 autoregulatory loop, a
cell may be able to independently tune the switching
threshold, the on-state expression level, and the extent of
memory in the network by separately modulating F1 and F2
(e.g., epigenetically). Second, there is an external checkpoint
(Epo) that modulates this autoregulatory loop. This is at-
tractive because it provides a novel and meaningful link
between canonically extrinsic (cytokine) and intrinsic (tran-
scription factor) signals in regulating not only cell survival
but also maturation.
The strengths of the positive feedback loops are governed
by the rates of transcription of GATA1 (F1) and EPOR (F2).
The estimated values of F1 and F2 are 0.04 and 0.123, re-
spectively. The difference in the rates of transcription of
EPOR (chromosome 19p13.2) and GATA1 (chromosome
Xp11.23) may be due to the distinct binding mechanisms of
GATA-1 to these promoters, dissimilarities in the ease of
accession of the GATA-1 binding sites, and the recruitment
of other cofactors that may regulate EPOR and GATA1
expression differently. GATA-1 also interacts with other
factors, notably the ubiquitous transcription factor Sp1, ery-
throid restricted factor EKLF, and friend of GATA-1 (FOG1)
that may alter its transcriptional activity among the various
GATA-1 regulated genes (29).
Though treated as constants in our model, F1 and F2 may
also change temporally during commitment and differentiation
due to additional biophysical (e.g., chromatin remodeling) and
biochemical (e.g., cofactor upregulation/downregulation)
processes. Accordingly, the values of F1 and F2 may also vary
substantially between primary cells and immortalized lines,
and may even differ among cell lines, depending upon how far
a cell line is from commitment toward the erythrocyte lineage,
relative expression of GATA-1 cofactors, basal levels of
EpoR and GATA-1 expression, and expression of antagonistic
transcription factors driving other lineages. Cell-speciﬁc
feedback strengths that differ signiﬁcantly from those used in
our models may serve to attenuate or amplify the actual effects
on the network.
Finally, system-level properties such as bistability and
ultrasensitivity that may be generally applicable to lineage
commitment can be experimentally corroborated. Pretreat-
ment of progenitor cells with ligand, as outlined in the Re-
sults section (Fig. 3), can be performed to show expected
hystereses in transcription factor activation and lineage com-
mitment. Additionally, the models elucidate how the steady-
state response proﬁles of activated transcription factor can be
inﬂuenced by F1 and F2, and these can be experimentally
validated by using pharmacological inhibitors or RNA inter-
ference to exogenously manipulate the values of F1 and F2.
Although the results presented here are motivated by the
EpoR/GATA-1 network and its critical role in erythropoiesis,
it will be interesting to see whether similar topologies are
uncovered in other cell systems that enable their hosts to make
robust decisions in response to external stimuli.
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